A Systematic Review on Co-Processed Formulation and Development

Abstract

The objective of this article is to review co-processed formulation and their development in pharmaceuticals. In formulation and development ofa specific dosage form, there is no single component that will fulfill all the requisites of formulation, this gave rise to the novel concept of co-processing. Co-processing is a combination of two or more excipients having specific quality and advantages. Nowadays co-processed excipients have received higher attention in the formulation and development of dosage form mainly in solid dosage form e.g. tablet manufacturing by direct compression. Advantage of co-processing excipients is that it will help both pharmaceutical industry and academicians to develop newer and novel dosage forms with better bioavailability and intended release profile. Furthermore, co-processing provides the opportunity for advancement to multifunctional excipients rather than multiple types of excipients in one formulation. The productivity, quality, and drug release profile of the formulation will be enhanced by co-processing. Many review articles are available on the co-processed formulation but those review articles are missing out on some of the other important aspects of co-processed formulation so, we are trying to cover all the aspects of co-processed formulation and their development also. We cover commercial status also so you will get all the information regarding co-processed formulation and development.